Back to Search
ASHLYN DAVIES, PHARM.D,
PHARM.D,
Pharmacist
NPI: 1740618438Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339).
PMID 19096312·J Thorac Oncol·2009
3-trial
Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation.
PMID 19494788·J Thorac Oncol·2009
3-trial
Extracellular signals regulating sympathetic neuron survival and target innervation during development.
PMID 19660992·Auton Neurosci·2009
6-review
Resuscitation-promoting factors are expressed in Mycobacterium tuberculosis-infected human tissue.
PMID 18440866·Tuberculosis (Edinb)·2008
8-other
Hypertension among adults in a deprived urban area of Peru - undiagnosed and uncontrolled?
PMID 18710540·BMC Res Notes·2008
8-other
Structure of a putative acetyltransferase (PA1377) from Pseudomonas aeruginosa.
PMID 18453699·Acta Crystallogr Sect F Struct Biol Cryst Commun·2008
8-other
Carbon monoxide-releasing molecule tricarbonyldichlororuthenium (II) dimer induces concentration-dependent alterations in the electrophysiological properties of axons in mammalian spinal cord.
PMID 18248914·Neuroscience·2008
7-preclinical
Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a.
PMID 18342608·Mol Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4175 E LA PALMA AVE STE 240
ANAHEIM, CA 92807 - Phone
- (714) 279-4698
Quick Facts
- NPI
- 1740618438
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile